✦ LIBER ✦

Guidance for Developing Phase II Cell Therapy Trial Proposals for Consideration by the Blood and Marrow Transplant Clinical Trials Network

✍ Scribed by Edwin M. Horwitz; Mary M. Horowitz; Nancy L. DiFronzo; Donald B. Kohn; Helen E. Heslop

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unrelated Donor Cord Blood Transplantati

✍ N.R. Kamani; M. Walters; S. Carter; J.A. Brochstein; M. Eapen; J.E. Levine; B. L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase II Trial of Non-Myeloablative Cond

✍ E.J. Fuchs; J. Wu; S. Carter; C.G. Brunstein; L.J. Costa; J.R. Wingard; M. Jagas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Optimization of Therapy for Severe Aplas

✍ Michael A. Pulsipher; Neal S. Young; Jakub Tolar; Antonio M. Risitano; H. Joachi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 447 KB

Low Risk of Chronic Graft-versus-Host Di

✍ Steven M. Devine; Shelly Carter; Robert J. Soiffer; Marcelo C. Pasquini; Parames 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Multicenter randomized phase II trial of

✍ Archimbaud, E; Jehn, U; Thomas, X; De Cataldo, F; Fillet, G; Belhabri, A; Peaud, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB